CEO cites AI safety concerns as the reason, despite a prior confidential IPO filing already in place.
Briefing
Rivian's $67bn IPO was the last mega-cap tech-adjacent listing to dominate Wall Street positioning pre-close. Its 75% share price collapse within 12 months demonstrated how anticipatory markups in late-stage private rounds misaligned with public market clearing prices, a structural risk now deferred rather than resolved for OpenAI investors.
WeWork's abandoned IPO, shelved after its S-1 exposed governance and valuation concerns, reset late-stage private market pricing across loss-making unicorns. The mechanism here differs, safety framing rather than fundamentals, but the secondary-market and VC markdown sequence that followed is a relevant precedent for OpenAI secondary holders.

Nasdaq's $100M investment in Kraken parent Payward at a $21B valuation, up 58% from Deutsche Börse's April entry, shows traditional exchanges aggressively pricing private AI and crypto infrastructure before public market liquidity events. The OpenAI delay extends the period during which private valuations are untested by public price discovery, amplifying the mispricing risk Nasdaq itself is taking on in adjacent private rounds.

Consensys splitting MetaMask into a standalone consumer company signals that high-profile private tech entities are restructuring for future fundraising or IPO optionality rather than rushing to market. The OpenAI delay reinforces this pattern: safety and regulatory optics, not valuation or market conditions alone, are now gating the largest prospective listings.
See Indexa more often on Google
Mark Indexa as a preferred source — your Top Stories will surface more Indexa coverage.
2 days ago